Yiwen Guo, Xulin Liu, Stephen Nicholas, Elizabeth Maitland, Rugang Liu
{"title":"重新审视全球HPV疫苗接种行为及其决定因素:全面回顾。","authors":"Yiwen Guo, Xulin Liu, Stephen Nicholas, Elizabeth Maitland, Rugang Liu","doi":"10.2147/RMHP.S524223","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Human papillomavirus (HPV) infection and the resulting penile, anal, oropharyngeal and cervical cancer impact the health and welfare of men and women. The HPV vaccine has emerged as the most effective method to combat HPV. This study comprehensively analyzes the key influencing factors of global HPV vaccination behavior.</p><p><strong>Methods: </strong>This systematic review synthesizes evidence on global HPV vaccination behaviors and determinants. We searched three major databases PubMed, Web of Science and Scopus for peer-reviewed literature published between 2018 and 2023. Studies from diverse geographical regions and population subgroups were analyzed using thematic synthesis and narrative approaches.</p><p><strong>Results: </strong>In the published literature, men and men who have sex with men (MSM) were under-represented groups. Both subjective and objective determinants influenced HPV vaccination behavior, including parental attitudes, knowledge of health professionals and gendered views about HPV risks. In the studies reviewed, HPV vaccination rates were low globally, with few countries achieving vaccination rates above 70%.</p><p><strong>Conclusion: </strong>Key HPV vaccination determinants included education level, parental attitudes, knowledge and awareness of HPV and its vaccine and acceptance of the HPV vaccine. Based on the literature survey, we provide recommendations for governments and health institutions to improve gender-specific HPV vaccination rates, including MSM.</p>","PeriodicalId":56009,"journal":{"name":"Risk Management and Healthcare Policy","volume":"18 ","pages":"2675-2689"},"PeriodicalIF":2.0000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12360388/pdf/","citationCount":"0","resultStr":"{\"title\":\"Revisiting Global HPV Vaccination Behavior and Its Determinants: A Comprehensive Review.\",\"authors\":\"Yiwen Guo, Xulin Liu, Stephen Nicholas, Elizabeth Maitland, Rugang Liu\",\"doi\":\"10.2147/RMHP.S524223\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Human papillomavirus (HPV) infection and the resulting penile, anal, oropharyngeal and cervical cancer impact the health and welfare of men and women. The HPV vaccine has emerged as the most effective method to combat HPV. This study comprehensively analyzes the key influencing factors of global HPV vaccination behavior.</p><p><strong>Methods: </strong>This systematic review synthesizes evidence on global HPV vaccination behaviors and determinants. We searched three major databases PubMed, Web of Science and Scopus for peer-reviewed literature published between 2018 and 2023. Studies from diverse geographical regions and population subgroups were analyzed using thematic synthesis and narrative approaches.</p><p><strong>Results: </strong>In the published literature, men and men who have sex with men (MSM) were under-represented groups. Both subjective and objective determinants influenced HPV vaccination behavior, including parental attitudes, knowledge of health professionals and gendered views about HPV risks. In the studies reviewed, HPV vaccination rates were low globally, with few countries achieving vaccination rates above 70%.</p><p><strong>Conclusion: </strong>Key HPV vaccination determinants included education level, parental attitudes, knowledge and awareness of HPV and its vaccine and acceptance of the HPV vaccine. Based on the literature survey, we provide recommendations for governments and health institutions to improve gender-specific HPV vaccination rates, including MSM.</p>\",\"PeriodicalId\":56009,\"journal\":{\"name\":\"Risk Management and Healthcare Policy\",\"volume\":\"18 \",\"pages\":\"2675-2689\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12360388/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Risk Management and Healthcare Policy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/RMHP.S524223\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Risk Management and Healthcare Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/RMHP.S524223","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
目的:人乳头瘤病毒(HPV)感染及其导致的阴茎、肛门、口咽和宫颈癌影响着男性和女性的健康和福祉。HPV疫苗已经成为对抗HPV最有效的方法。本研究综合分析了全球HPV疫苗接种行为的关键影响因素。方法:本系统综述综合了全球HPV疫苗接种行为及其决定因素的证据。我们检索了三个主要数据库PubMed、Web of Science和Scopus,以获取2018年至2023年间发表的同行评议文献。采用主题综合和叙述方法分析了来自不同地理区域和人口亚群的研究。结果:在已发表的文献中,男性和男男性行为者(MSM)是代表性不足的群体。主观和客观的决定因素都影响HPV疫苗接种行为,包括父母的态度、卫生专业人员的知识和性别对HPV风险的看法。在所审查的研究中,全球HPV疫苗接种率很低,很少有国家的疫苗接种率达到70%以上。结论:HPV疫苗接种的关键决定因素包括受教育程度、父母态度、HPV及其疫苗的知识和意识以及HPV疫苗的接受程度。根据文献调查,我们为政府和卫生机构提供建议,以提高性别特异性HPV疫苗接种率,包括MSM。
Revisiting Global HPV Vaccination Behavior and Its Determinants: A Comprehensive Review.
Purpose: Human papillomavirus (HPV) infection and the resulting penile, anal, oropharyngeal and cervical cancer impact the health and welfare of men and women. The HPV vaccine has emerged as the most effective method to combat HPV. This study comprehensively analyzes the key influencing factors of global HPV vaccination behavior.
Methods: This systematic review synthesizes evidence on global HPV vaccination behaviors and determinants. We searched three major databases PubMed, Web of Science and Scopus for peer-reviewed literature published between 2018 and 2023. Studies from diverse geographical regions and population subgroups were analyzed using thematic synthesis and narrative approaches.
Results: In the published literature, men and men who have sex with men (MSM) were under-represented groups. Both subjective and objective determinants influenced HPV vaccination behavior, including parental attitudes, knowledge of health professionals and gendered views about HPV risks. In the studies reviewed, HPV vaccination rates were low globally, with few countries achieving vaccination rates above 70%.
Conclusion: Key HPV vaccination determinants included education level, parental attitudes, knowledge and awareness of HPV and its vaccine and acceptance of the HPV vaccine. Based on the literature survey, we provide recommendations for governments and health institutions to improve gender-specific HPV vaccination rates, including MSM.
期刊介绍:
Risk Management and Healthcare Policy is an international, peer-reviewed, open access journal focusing on all aspects of public health, policy and preventative measures to promote good health and improve morbidity and mortality in the population. Specific topics covered in the journal include:
Public and community health
Policy and law
Preventative and predictive healthcare
Risk and hazard management
Epidemiology, detection and screening
Lifestyle and diet modification
Vaccination and disease transmission/modification programs
Health and safety and occupational health
Healthcare services provision
Health literacy and education
Advertising and promotion of health issues
Health economic evaluations and resource management
Risk Management and Healthcare Policy focuses on human interventional and observational research. The journal welcomes submitted papers covering original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports. Case reports will only be considered if they make a valuable and original contribution to the literature. The journal does not accept study protocols, animal-based or cell line-based studies.